J.P. Morgan Notebook Day 2: Walmsley On Diversity, Amgen's Overseas Cash, Growing Opdivo, Mylan On US Generic Pricing, Boston's Pipeline And J&J In Alzheimer's

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.